|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Covidien |
| Information provided by: | Covidien |
| ClinicalTrials.gov Identifier: | NCT00596973 |
Purpose
The aim of this study is to assess the short term success and feasibility of ileal transposition with sleeve gastrectomy in non-morbidly obese patients with poorly controlled Type 2 Diabetes Mellitus
| Condition | Intervention | Phase |
|
Diabetes |
Procedure: Surgical Treatment |
Phase IV |
| MedlinePlus related topics: | Diabetes Obesity |
| Study Type: | Interventional |
| Study Design: | Treatment, Open Label, Single Group Assignment, Safety/Efficacy Study |
| Official Title: | Phase IV Study of Surgical Treatment of Type 2 Diabetes in Non-Morbidly Obese Patients |
| Estimated Enrollment: | 10 |
| Study Start Date: | January 2008 |
| Estimated Study Completion Date: | March 2009 |
| Estimated Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
Eligibility
| Ages Eligible for Study: | 35 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Emily Westheimer | Emily.Westheimer@mountsinai.org |
| United States, New York | |||||
| Mount Sinai School of Medicine | Recruiting | ||||
| New York, New York, United States, 10029 | |||||
| Covidien |
| Principal Investigator: | Barry Salky, MD | Mount Sinai School of Medicine |
More Information
| Responsible Party: | US Surgical ( Ross D. Segan, MD, FACS Global Medical Director ) |
| Study ID Numbers: | AS07007 |
| First Received: | November 28, 2007 |
| Last Updated: | January 8, 2008 |
| ClinicalTrials.gov Identifier: | NCT00596973 |
| Health Authority: | United States: Institutional Review Board |
|
|